Science & Research jobs

Senior Manager, Pre-Formulation and Formulation Development

ArvinasNew Haven, CTOn-sitePosted 3 days ago

Pay not listed

Key facts

Experience
5+ years
US visa
No US visa sponsorship

Looks real. 1 thing to check before you apply.

On Arvinas’ own careers site (Greenhouse), checked open today.

  • To check: No pay range listed, though one is likely required in CTAsk for the pay range before you interview. The law here likely requires one.
  • Checked: On the company's own careers siteGreenhouse board
  • Checked: Checked open todayGreenhouse board
  • Trust score 89 / 100 · Looks good
See all 4 checksShow fewer
How we check

What you’ll do

  • Plan and conduct pre-formulation and formulation studies, characterizing compounds and recommending phase-appropriate formulations.
  • Develop oral and parenteral animal dosing formulations and establish concentration, homogeneity, stability, robustness, and hold times.
  • Develop early clinical formulations, including spray-dried amorphous solid dispersions, tablets, and parenteral prototypes.
  • Coordinate formulation testing, stability assessments, technology transfer, and CRO or manufacturing partner deliverables.

Summarised from the posting by AI and can be wrong. The full description is the source.

Requirements

Experience

  • 5+ years of relevant pharmaceutical or biotechnology experience in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline
  • Hands-on pre-formulation and early formulation development, technical project leadership, and mentoring
  • Repeated contributions to IND-enabling and early clinical programs
  • Direct experience with oral and parenteral animal formulations, non-GLP/GLP study support, dose-formulation controls, and transfer to CROs or study sites
  • Spray drying and amorphous solid dispersion experience
  • Tableting and parenteral formulation development experience, including practical formulation evaluation and collaboration with manufacturing partners
  • Experience with PEG-containing drug candidates and working knowledge of biologics formulation, including protein stability, aggregation, adsorption, buffers, and excipients
  • Later-stage and commercial experience (preferred)

Skills

  • Ability to interpret physicochemical and analytical data, including HPLC/UPLC, particle-size, DSC, TGA, and XRPD results
  • Working knowledge of GLP, early clinical cGMP, data integrity, and technology transfer

On the job

  • Ability to perform essential on-site laboratory duties with appropriate PPE and reasonable accommodation, where needed
  • Ability to lift/carry 15 pounds unassisted and 30 pounds assisted; work around biological, infectious, and hazardous materials; gown and degown PPE; use a computer; and maintain general availabilityภ

Other requirements

  • Ability to work without a need for current or future VISA sponsorship
  • On-site work in New Haven, Connecticut

Your match

Sign in and add your resume to see which of this job's requirements it shows.

Sign in to check your match

Saved to your account, encrypted. The AI that reads it doesn't keep it or train on it.

Benefits

Health insurance
Group medical coverage
Dental & vision
Group vision and dental coverage
Bonus
Incentive compensation
Life & disability insurance
Group and supplemental life insurance

Full job description

From Arvinas’ careers site

Arvinas is a biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer PROteolysis TArgeting Chimeras, or PROTACs, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

Show full descriptionShow less

This differentiated approach has enabled Arvinas to build a broad pipeline of investigational therapies across oncology and neurodegenerative diseases, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle for spinal bulbar muscular atrophy; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer.

Building on its leadership in targeted protein degradation, Arvinas achieved a major milestone in May 2026 with the first-ever U.S. Food and Drug Administration (FDA) approval of a PROTAC protein degrader therapy. The approval marked a significant advancement for the field and demonstrated the therapeutic potential of targeted protein degradation as a novel treatment modality. This PROTAC has been out-licensed for commercialization and further development.

#TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.

Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on LinkedIn and X.

Position Summary

The incumbent will combine hands-on pre-formulation expertise with practical oral and parenteral formulation development, moving flexibly between these functions as programs evolve. Responsibilities span compound characterization, animal and toxicology dosing formulations, and first-in-human and Phase 2 drug products, including formulation optimization and technology transfer.

Working with the Drug Product Development team, the role will interpret data, recommend formulations, and deliver creative, phase-appropriate solutions across multiple early-stage programs. Priorities will be agreed with the Head of CMC Technical Operations who leads overall drug product strategy.

This on-site role in New Haven, CT requires regular hands-on laboratory work and reports to the Head of CMC Technical Operations, with a dotted reporting line to the Drug Product Development.

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

  • Plan and execute pre-formulation and formulation studies, balancing compound characterization, preclinical dosing needs, and Phase 1/2 formulation development against agreed priorities, material availability, and timelines.
  • Characterize solubility, dissolution, solid-state and particle properties, chemical and physical stability, and excipient compatibility. Interpret analytical and relevant in vivo findings to recommend formulations with Drug Product Development.
  • Develop oral and parenteral animal formulations for pharmacokinetic, efficacy, and non-GLP/GLP toxicology studies. Align vehicle, concentration, dose volume, route, tolerability, and preparation requirements with study teams.
  • Establish dosing-formulation concentration, homogeneity, stability, robustness, and supported hold times with analytical specialists. Transfer reproducible procedures to CROs and resolve formulation issues with Toxicology, DMPK, and QA.
  • Develop early clinical formulations, including spray-dried amorphous solid dispersions and tablets. Screen polymers, solvents, excipients, and processes and assess loading, stability, residual solvents, and dosage-form performance.
  • Develop parenteral prototypes, evaluating pH, osmolality, stability, and dilution and administration compatibility. Apply PEG experience and biologics formulation knowledge, including aggregation and adsorption, with specialist support.
  • Coordinate formulation testing, stability, in-use assessments, and clinical-scale transfer with Drug Product Development, Analytical Development, QA, and qualified manufacturing partners; identify comparison or bridging needs.
  • Manage assigned vendor scopes, technical deliverables, timelines, and approved spend. Prepare development reports, formulation instructions, transfer packages, and relevant CMC content with traceable records and applicable GLP/cGMP compliance.
  • Use focused experiments and documented risk assessments to advance programs efficiently under material, data, and time constraints. Mentor colleagues and maintain laboratory safety, product quality, and compliance.

Qualifications

  • Strong hands-on pre-formulation and formulation experience, with repeated contributions to IND-enabling and early clinical programs. Ability to move between both functions and solve solubility and stability challenges creatively.
  • Direct experience with oral and parenteral animal formulations, non-GLP/GLP study support, dose-formulation controls, and transfer to CROs or study sites.
  • Spray drying and amorphous solid dispersion experience is required. Tableting and parenteral formulation development experience are required, including practical formulation evaluation and collaboration with manufacturing partners.
  • Experience with PEG-containing drug candidates and working knowledge of biologics formulation, including protein stability, aggregation, adsorption, buffers, and excipients; ability to engage specialists appropriately.
  • Ability to interpret physicochemical and analytical data, including relevant HPLC/UPLC, particle-size, DSC, TGA, and XRPD results. Working knowledge of GLP, early clinical cGMP, data integrity, and technology transfer.
  • Arvinas will not be providing VISA sponsorship for this position now or in the future. You must have the ability to work without a need for current or future VISA sponsorship.
  • The duties of this role are generally conducted in a combination of office and lab environment. Employees must be able, with or without an accommodation to lift/carry 15/30 pounds unassisted/assisted; work comfortable in a controlled environment with and around biological, infectious and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving, analysis and dialogue; collaborate with others; maintain general availability during standard business hours.

EDUCATION

  • 5+ years of relevant pharmaceutical or biotechnology experience in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline, including hands-on pre-formulation and early formulation development, technical project leadership, and mentoring.

Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com

  • Strong experimental design, technical leadership, vendor management, communication, and mentoring skills. Later-stage and commercial experience are desirable, not required. Ability to perform essential on-site laboratory duties with appropriate PPE and reasonable accommodation, where needed.

Arvinas is an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identify, national origin, disability or protected veteran status.

Something wrong with this job? Report it · This flag looks wrong

Similar jobs

Senior Scientist

Eurofins · Groton, CT

Full-timeOn-site

Looks goodPay not listedChecked open todayPosted yesterday

See more like this